---
title: "Sino Biopharmaceutical drops 5% in Hong Kong trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306230085.md"
description: "Sino Biopharmaceutical fell 5.22% to HK$5.085. Down 8.54% over five sessions and down 16.09% YTD."
datetime: "2026-11-20T06:52:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306230085.md)
  - [en](https://longbridge.com/en/news/306230085.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306230085.md)
generator: "portal-rs"
---

# Sino Biopharmaceutical drops 5% in Hong Kong trading

Sino Biopharmaceutical (1177.HK) fell more than **5%** in Hong Kong trading, last at **HK$5.085**.

The stock is down 8.54% over the past five sessions and down 16.09% year to date. It sits 29.18% below its 52-week high of HK$7.180.

The Hang Seng Index is down 5.51% over the past five sessions and down 12.86% year to date.

The pharmaceuticals industry index fell 4.0% over the same period, in line with the stock's move.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)

## Related News & Research

- [Will Cancer Drug Partnership Change Sino Biopharmaceutical's (SEHK:1177) Narrative](https://longbridge.com/en/news/305490163.md)
- [China’s burgeoning novel medicines success presents opportunity for Europe](https://longbridge.com/en/news/305007877.md)
- [Boehringer signs oncology deal with Sino Biopharm worth up to $7.4bn](https://longbridge.com/en/news/304298771.md)
- [Sino Biopharm Surges After Striking Over USD7 Billion Cancer Drug Deal With Boehringer Ingelheim](https://longbridge.com/en/news/304378912.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**